Publications by the researcher in collaboration with Enrique Quintero Carrión (39)

2024

  1. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions

    Gastric Cancer, Vol. 27, Núm. 4, pp. 747-759

  2. Development and validation of a faecal immunochemical test-based model in the work-up of patients with iron deficiency anaemia

    Frontiers in Medicine, Vol. 11

2023

  1. Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study

    United European Gastroenterology Journal, Vol. 11, Núm. 7, pp. 692-699

  2. Rates of repeated colonoscopies to clean the colon from low-risk and high-risk adenomas: Results from the EPoS trials

    Gut, Vol. 72, Núm. 5, pp. 951-957

  3. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)

    PLoS Medicine, Vol. 20, Núm. 10

2020

  1. Retrospective cohort study: Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test

    World Journal of Gastroenterology, Vol. 26, Núm. 1, pp. 70-85

  2. Validation of miR-1228-3p as housekeeping for microRNA analysis in liquid biopsies from colorectal cancer patients

    Biomolecules, Vol. 10, Núm. 1

  3. Variation in Colonoscopy Performance Measures According to Procedure Indication

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 5, pp. 1216-1223.e2

2019

  1. Correction: Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer (Clinical and Translational Gastroenterology, (2019) 10, e-00031, 10.14309/ctg.0000000000000003)

    Clinical and Translational Gastroenterology

  2. Endoscopic surveillance after colonic polyps and colorrectal cancer resection. 2018 update

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 3, pp. 188-201

  3. High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome

    Endoscopy, Vol. 51, Núm. 2, pp. 142-151

  4. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer

    Clinical and translational gastroenterology, Vol. 10, Núm. 1, pp. e00003

2018

  1. Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update

    Gastroenterologia y Hepatologia, Vol. 41, Núm. 9, pp. 585-596

  2. Detection of serrated lesions in proximal colon by simulated sigmoidoscopy vs faecal immunochemical testing in a multicentre, pragmatic, randomised controlled trial

    United European Gastroenterology Journal, Vol. 6, Núm. 10, pp. 1527-1537

  3. Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia

    United European Gastroenterology Journal, Vol. 6, Núm. 1, pp. 123-130

  4. Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox

    United European Gastroenterology Journal, Vol. 6, Núm. 4, pp. 622-629

  5. Plasma miRNAs signature validation for early detection of colorectal cancer

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. v106

2017

  1. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs

    United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260

  2. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients

    International Journal of Cancer, Vol. 140, Núm. 10, pp. 2201-2211

2016

  1. Colorectal cancer risk factors in patients with serrated polyposis syndrome: A large multicentre study

    Gut, Vol. 65, Núm. 11, pp. 1829-1837